1 Center for Nuclear Technologies, Technical University of Denmark2 Radiation Physics, Center for Nuclear Technologies, Technical University of Denmark3 Copenhagen University Hospital
The overall objective of this work is to establish alanine dosimetry for traceable measurements in clinical radiotherapy beams, in particular for non-reference situations such as small field sizes and composite beam delivery (e.g. intensity modulated radiotherapy and volumetric modulated arc therapy). To this end, we here present the results of a Monte Carlo simulation study with DOSRZnrc that investigated the influence of field and detector size for small 6 MV photon beams. The study focusses on doses averaged over the volume of the detector rather than point doses.The ratio of volume averaged doses to water (D¯W) and alanine (D¯det) was found to be approximately 1.025 for most situations studied, and a constant ratio is likely to be representative for many applications in radiation therapy. However, D¯W/D¯det was found to be as low as 0.9908 ± 0.0037 in situations where one might expect significant deviations from charged particle equilibrium (i.e. at shallow depths and when the field size was smaller than the range of the secondary electrons). These effects therefore need consideration when finite-size alanine dosimeters are used under such conditions.
Radiation Measurements, 2012, Vol 47, Issue 10, p. 1014-1017
Alanine; Small field; Correction factor; Monte Carlo